HCA Healthcare, Inc. (NYSE:HCA) Stock Holdings Increased by Carmel Capital Partners LLC

Carmel Capital Partners LLC boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 18.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,275 shares of the company’s stock after buying an additional 808 shares during the quarter. Carmel Capital Partners LLC’s holdings in HCA Healthcare were worth $1,583,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. FMR LLC boosted its stake in HCA Healthcare by 322.3% in the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after acquiring an additional 2,397,883 shares during the period. Franklin Resources Inc. boosted its stake in HCA Healthcare by 11.7% in the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock valued at $660,842,000 after acquiring an additional 174,946 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in HCA Healthcare by 2.8% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock valued at $604,511,000 after acquiring an additional 41,190 shares during the period. Janus Henderson Group PLC boosted its stake in HCA Healthcare by 12.0% in the third quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock valued at $544,467,000 after acquiring an additional 143,995 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in HCA Healthcare by 0.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,149,043 shares of the company’s stock valued at $344,885,000 after acquiring an additional 6,590 shares during the period. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $320.03 on Thursday. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The business has a fifty day simple moving average of $315.76 and a 200 day simple moving average of $348.17. The firm has a market cap of $79.48 billion, a price-to-earnings ratio of 14.57, a P/E/G ratio of 1.10 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the prior year, the business earned $5.90 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be given a $0.72 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.90%. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Insider Activity

In other news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on HCA shares. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Cantor Fitzgerald reiterated an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. Royal Bank of Canada reduced their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday, January 27th. Morgan Stanley reduced their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Finally, Truist Financial decreased their price target on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.